Bionano genomics announces publication of study using ogm for detection of balanced chromosomal rearrangements found in recurrent pregnancy loss

San diego, sept. 21, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced the publication of a study utilizing ogm to detect cryptic balanced chromosomal rearrangements (bcrs) found in subjects who experienced recurrent pregnancy loss (rpl). compared to traditional cytogenetic methods, ogm successfully identified cryptic reciprocal translocation in all samples, improving the success rate for finding pathogenic variants of cryptic bcrs and streamlining the process of detection.
BNGO Ratings Summary
BNGO Quant Ranking